Rani Therapeutics Value At Risk
| RANI Stock | | | USD 1.06 -0.08 -7.02% |
The Value At Risk reading for Rani Therapeutics Holdings is computed from historical trading observations. Broader indicator relationships are reflected within
Equity Screeners. Rani Therapeutics has a market cap of 138.59 M, operating margin of -34.18%, current ratio of 14.02. Use
Your Equity Center to view allocation positioning. Tracking Rani Therapeutics Holdings in a portfolio provides context for performance attribution. Sector and industry exposure becomes visible in the portfolio breakdown. Broader economic conditions can influence Rani Therapeutics Holdings's company valuation — related indicators include
signals in inflation.
Rani Therapeutics Holdings has current Value At Risk of
-5.47. Value At Risk (or VAR) is a statistical technique used to measure the level of financial risk of investment instrument over a specific time frame. It is a widely used measure of the risk of loss on a specific investing instrument.
Value At Risk | = | ER[a] x N | + | (Z-SCORE x STD x SQRT (N)) |
| = | -5.47 | |
| ER[a] | = | Expected return on investing in Rani Therapeutics |
| STD | = | Standard Deviation of Rani Therapeutics |
| N | = | Number of points for the period |
| Z-SCORE | = | Number of standard deviations above or below the mean |
Value At Risk Peers Comparison
Value At Risk Relative To Other Indicators
Rani Therapeutics Holdings places
third for value at risk among direct rivals. It is currently under evaluation for maximum drawdown among direct rivals .
Value At Risk is used by risk managers in order to measure and control the level of risk which the firm undertakes. The risk manager job is to ensure that risks are not taken beyond the level at which the firm can absorb the losses of a probable worst outcome. VAR can be defined as the loss level that will not be exceeded with a certain confidence level during a certain period of time.
Compare Rani Therapeutics to Peers
Other Technical Indicators